Drawing for Serial No. 98052447

USPTO serial 98052447

Serial No. 98052447

Reviewed by CopyMark Law Group

Reg. 7533120Status 700Registered
Filing date
Status date
Registration date
Oct 15, 2024
Examiner
LAMONT, MIAH ROSENBERG
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with Serial No. 98052447?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Haverly MacArthur

Haverly MacArthur ADAMS AND REESE LLP1600 WEST END AVENUESUITE 1400NASHVILLE, TN 37203

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations and veterinary preparations for strengthening the immune system and restoring normal bodily immune system functions; pharmaceutical preparations and veterinary preparations for the treatment, mitigation and prevention of diseases and disorders, namely, digestive diseases and disorders and obesity; pharmaceutical preparations and veterinary preparations for central nervous system diseases and disorders, namely, brain diseases, cognitive disorders, movement disorders, and ocular motility; pharmaceutical preparations and veterinary preparations for respiratory diseases and disorders; pharmaceutical preparations and veterinary preparations for excretory diseases and disorders; pharmaceutical preparations and veterinary preparations for cardiovascular diseases and disorders; pharmaceutical preparations and veterinary preparations for reproductive diseases and disorders; pharmaceutical preparations and veterinary preparations for endocrinal diseases and disorders; pharmaceutical preparations and veterinary preparations for immunological diseases and disorders, namely, autoimmune diseases, immunologic deficiency syndrome, and hepatitis; pharmaceutical preparations and veterinary preparations for dermatological diseases and disorders; pharmaceutical preparations and veterinary preparations for bone diseases, back pain, muscular dystrophy and inflammatory muscle diseases; pharmaceutical preparations and veterinary preparations for blindness; sanitary preparations for medical purposes, other than toiletries; dietetic food adapted for medical use; food for babies; dietary supplements for human beings and animals; plasters for medical purposes; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides; nutritional supplements; Chinese patent medicines for the treatment of tumors and for enhancing the immune system; herbal supplements, namely, lingzhi; herbal supplements, namely, yunzhi; herbal supplements in the form of granules, pills, capsules and tablets containing yunzhi for the treatment of cancer and cancer affections; herbal supplements in the form of granules, pills, capsules and tablets containing lingzhi for the treatment of cancer and cancer affections; herbal supplements containing yunzhi being corioulus versicolor in the form of capsules, granules, pills and tablets for the treatment of tumors and for enhancing the immune systemACTIVE—
042Scientific research in the medical and pharmaceutical fields and in the fields of drug discovery and mechanism delineation; scientific and technological services, namely, scientific research in the fields of drug discovery and mechanism delineation; scientific and technological services, namely, scientific testing in the field of pharmaceutical products, health food products and Chinese medicines; scientific and technological research and development services in the field of pharmaceutical products, health food products and Chinese medicines; scientific research in the field of biomedical materials; biotechnology testing in the nature of testing of pharmaceuticals; development and testing of medicines; research and development of pharmaceuticals and medicines; drug discovery services; testing, inspection or research of pharmaceuticals, cosmetics or foodstuff; food safety testing services; quality control for others; quality control for others related to food hygiene; industrial research services in the field of pharmaceutical products, health food products and Chinese medicines; design and development of computer hardware and software; consulting and advisory services in the field of research and development of pharmaceutical products, health food products and Chinese medicinesACTIVE—
044Medical services; veterinary services; hygienic and beauty care for humans and animals; agricultural advice; horticultural services; medical clinic services; providing medical consultancy and advisory services on pharmaceutical products, health food products and Chinese medicines; advisory and consulting services relating to health and beauty care; providing information relating to the foregoing; medical testing services for diagnostic or treatment purposesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 15, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Oct 15, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 30, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 30, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 10, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 26, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 12, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 12, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 12, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 14, 2024GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 14, 2024GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 14, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 8, 2024DOCKASSIGNED TO EXAMINER—
Jul 25, 2023MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Jul 24, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 24, 2023NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance